Fat Loss & Metabolic Health

What Are Research Insights on Retatrutide for Neuroendocrine Appetite Dysregulation in Binge Eating Disorder?

The research question at the center of this article is narrow and worth stating plainly: what do the current data allow researchers…

Is Cagrilintide a Promising Investigational Approach for Reducing Prediabetes Risk?

Prediabetes is an intermediate, still-reversible stage of glucose dysregulation in which fasting or post-load blood sugar sits above normal but below the…

Orforglipron vs Semaglutide vs Tirzepatide: Oral GLP-1 in Research

For more than a decade the entire incretin class shared one inconvenient trait: it lived inside a needle. Semaglutide, tirzepatide, and the…

What Is Orforglipron? The Oral GLP-1 Pill Explained for Research

Orforglipron (developmental code LY3502970, brand name Foundayo) is the first orally administered, small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist to reach late-stage development…

Does Semaglutide Play a Role in Nonalcoholic Fatty Liver Disease Research?

Few peptides have moved from metabolic research into hepatology as rapidly as semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist whose weight-lowering…

Tirzepatide Dosage & Titration: The Complete Protocol

Tirzepatide is a dual GIP + GLP-1 receptor agonist dosed once weekly and escalated slowly to protect gut tolerability. This complete research-use-only…

Semaglutide Dosage & Titration: The Complete Protocol

A clinical-grade, research-use-only reference for the documented semaglutide weekly titration ladder (0.25 to 2.4 mg), with reconstitution math for 5, 10 and…

Retatrutide Dosage & Titration: The Complete Escalation Protocol

A clinical, research-use-only reference for the documented Retatrutide protocol: the week-by-week titration ladder, reconstitution math for every vial size from 5 to…

5-Amino-1MQ Dosage: How Much Per Day, Route & the Complete Protocol

A complete, research-use-only 5-Amino-1MQ protocol: the documented per-day amounts for the 10 mg and 50 mg vials, the oral-vs-subcutaneous route question answered…

GLP-1 Showdown: Retatrutide vs. Semaglutide vs. Tirzepatide — How the Research Compares

Two of these compounds are FDA-approved medicines with years of human data; the third is still investigational. Here is the honest three-way…